StockIQStockIQ.tech

REGENXBIO Inc. (RGNX) Stock Analysis

--

Free AI-powered analysis and research for REGENXBIO Inc. stock

Sector: Healthcare

Full RGNX report

REGENXBIO Inc. (RGNX) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze RGNX Now β†’

πŸ“° Latest Update

Wall Street Analysts See a 214.55% Upside in Regenxbio (RGNX): Can the Stock Really Move This High?

Regenxbio (RGNX) closed at $7.63, with Wall Street analysts projecting a mean price target of $24, suggesting a potential upside of 214.6%. The targets range from $10.00 to $50.00, with a standard deviation of $11.67, indicating a consensus among analysts about the stock's direction. Despite the optimistic outlook, the article cautions that price targets should be approached with skepticism, as they may not accurately predict actual stock movements.

Read full article β†’

History

People also watch

LLY
Eli Lilly and Company
--
PFE
Pfizer Inc.
--
UNH
UnitedHealth Group Inc.
--
LNTH
Lantheus Holdings, Inc.
--
BNGO
Bionano Genomics, Inc.
--